1-3 of 3
Zhengping Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Carfilzomib in Patients (Pts) with Relapsed and Refractory Multiple Myeloma (MM) and Varying Degrees of Renal Insufficiency.

Ashraf Z. Badros, MD, Ravi Vij, MD, Thomas Martin, MD, Jeffrey A Zonder, MD, Tina Woo, Zhengping Wang, Susan Lee, Alvin Wong, PharmD, Ruben Niesvizky, MD
Journal: Blood
Blood (2009) 114 (22): 3877.
https://doi.org/10.1182/blood.V114.22.3877.3877
Published: 2009
Journal Articles

Dose Intensive Administration of PR-047, a Novel Orally Bioavailable Inhibitor of the 20S Proteasome, Is Well Tolerated in Experimental Animals.

Tony Muchamuel, Shirin Kapur, PhD, Christopher J Kirk, Ph.D, Jing Jiang, M.D., Susan Lee, Mark K Bennett, PhD, Evan Lewis, Jinfu Yang, Mouhannad Jumaa, Eileen Ring, Pasit Phiasivongsa, Han-Jie Zhou, PhD, Zhengping Wang
Journal: Blood
Blood (2009) 114 (22): 4910.
https://doi.org/10.1182/blood.V114.22.4910.4910
Published: 2009
Journal Articles

Pharmacokinetics, Metabolism, Distribution and Excretion of Carfilzomib in Rats.

Jinfu Yang, Rachel Fang, Zhengping Wang, Jing Jiang, Tony Muchamuel, Susan Lee, Christopher J Kirk, Francisco Zhao, Mark K Bennett, Christopher J. Molineaux
Journal: Blood
Blood (2009) 114 (22): 2754.
https://doi.org/10.1182/blood.V114.22.2754.2754
Published: 2009